JPRN-UMIN000016582已完成1 期
Phase I clinical safety study of Enzyme-treated Asparagus Extract (ETAS) by the healthy subjects (a randomized placebo-controlled trial) - The phase I safety study of Enzyme-treated Asparagus Extract (ETAS)
Osaka University Graduate School of Medicine, Department of Integrative Medicine0 个研究点目标入组 50 人开始时间: 2015年4月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
Severe side effects associated with taking formulation were not observed.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe clinical history 2) Pregnancy or the subjects to desire it. 3) Lactation period 4) The subject who cannot measure the body composition by bioelectrical impedance analysis because of equipment of medical machine such as pacemaker or severe dry skin. 5) The case that the doctor judged to be unsuitable for the participation of this examination
研究者
相似试验
招募中
1 期
Study BT5528-100 in Patients with Advanced Solid Tumors Associated with EphA2 ExpressioAdvanced Malignancies Associated with EphA2 ExpressionMedDRA version: 21.1Level: LLTClassification code: 10065147Term: Malignant solid tumor Class: 10029104CTIS2024-510655-36-00Bicycletx Limited288
进行中（未招募）
1 期
A Phase 1-2 Study of the Safety and Activity of ASTX029 in Patients with Advanced Solid TumorsAdvanced Solid TumorsMedDRA version: 21.1Level: LLTClassification code 10065147Term: Malignant solid tumorSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10053571Term: MelanomaSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10029514Term: Non-small cell lung cancer NOSSystem Organ Class: 100000004864EUCTR2018-004568-72-ESAstex Pharmaceuticals, Inc.300
进行中（未招募）
1 期
A Phase 1-2 Study of the Safety and Activity of ASTX029 in Patients with Advanced Solid TumorsAdvanced Solid TumorsMedDRA version: 21.1Level: LLTClassification code 10065147Term: Malignant solid tumorSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10053571Term: MelanomaSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10029514Term: Non-small cell lung cancer NOSSystem Organ Class: 100000004864EUCTR2018-004568-72-FRAstex Pharmaceuticals, Inc.300
尚未招募
1 期
The study to determine whether the child friendly formulations for drug resistant tuberculosis are safe, tolerable and acceptable among children below 15 years of age.CTRI/2020/09/027512Stellenbosch University
进行中（未招募）
1 期
Study of the Safety and Pharmacokinetics of Venetoclax in Children and Young Adults with Relapsed or Refractory MalignanciesEUCTR2017-000439-14-FRAbbVie Deutschland GmbH & Co. KG135